Why is Morepen Labs. falling/rising?

As of 17-Jul, Morepen Laboratories Ltd is experiencing a decline in its stock price, currently at 63.20, which reflects a decrease of 0.29 or 0.46%. Today's price summary indicates that the stock has underperformed its sector by 0.88% and has fallen after three consecutive days of gains. In terms of returns, the stock has shown a negative performance over the past week and month, with declines of 0.47% and 0.77%, respectively, while it has a year-to-date drop of 19.28%. Despite these short-term setbacks, the company has demonstrated healthy long-term growth with an operating profit growth rate of 35.63% and a return on equity (ROE) of 10.2. However, negative quarterly results reported in March, including a significant drop in profit after tax (PAT) by 35.5%, may have contributed to the stock's recent downward movement, alongside the lack of domestic mutual fund investment which suggests a lack of confidence in the stock's current valuation.
In the broader market context, Morepen Laboratories Ltd's recent performance contrasts with the benchmark Sensex, which has shown a decline of 1.12% over the past week, indicating that the stock has outperformed the market slightly in this timeframe. However, the stock's year-to-date performance remains significantly lower than the Sensex's gain of 5.27%. The stock's liquidity appears adequate for trading, with a delivery volume increase of 22.48% against the five-day average, suggesting some investor interest despite the overall negative sentiment reflected in its recent price movements.